Sanofi has launched its new insulin treatment Toujeo in the UK, and says it will be priced at the same level as its big seller Lantus. The pricing decision matches Sanofi's approach in the US ...

Sanofi’s Toujeo – a follow-up to its long-acting insulin drug Lantus – has underperformed commercially since launch but the company hopes new data could help it gather momentum. The French ...

Collection Group Methodology: How TIME and Statista Determined the World's Most Sustainable Companies of 2025 In the fight against climate change, companies are navigating compounding ...

Sanofi India Share Price Today 7 Jul 2025: Track Sanofi India share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial ...